{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T11:46:01Z","timestamp":1778499961091,"version":"3.51.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1038\/s41390-022-02098-5","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T14:03:16Z","timestamp":1652191396000},"page":"233-241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Optic pathway glioma and endocrine disorders in patients with and without NF1"],"prefix":"10.1038","volume":"93","author":[{"given":"Merav","family":"Gil Margolis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Yackobovitz-Gavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Toledano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariel","family":"Tenenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roni","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moshe","family":"Phillip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shlomit","family":"Shalitin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,10]]},"reference":[{"key":"2098_CR1","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s00381-021-05060-8","volume":"37","author":"CS Hill","year":"2021","unstructured":"Hill, C. S. et al. Neurosurgical experience of managing optic pathway gliomas. Childs Nerv. Syst. 37, 1917\u20131929 (2021).","journal-title":"Childs Nerv. Syst."},{"key":"2098_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.critrevonc.2016.05.008","volume":"104","author":"J Helfferich","year":"2016","unstructured":"Helfferich, J. et al. Neurofibromatosis type 1 associated low-grade gliomas: a comparison with sporadic low-grade gliomas. Crit. Rev. Oncol. Hematol. 104, 30\u201341 (2016).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"2098_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1001\/archneurpsyc.1958.02340060003001","volume":"79","author":"HW Dodge","year":"1958","unstructured":"Dodge, H. W. et al. Glioma of the optic nerves. Arch. Neurol. Psych. 79, 607\u2013621 (1958).","journal-title":"Arch. Neurol. Psych."},{"key":"2098_CR4","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1259\/bjr\/65246351","volume":"81","author":"T Taylor","year":"2008","unstructured":"Taylor, T. et al. Radiological classification of optic pathway gliomas: experience of a modified functional classification system. Br. J. Radiol. 81, 761 (2008).","journal-title":"Br. J. Radiol."},{"key":"2098_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/peds.2019-0660","volume":"143","author":"DT Miller","year":"2019","unstructured":"Miller, D. T. et al. Health supervision for children with neurofibromatosis type 1. Pediatrics 143, 1\u201316 (2019).","journal-title":"Pediatrics"},{"key":"2098_CR6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0022-3476(95)70449-3","volume":"126","author":"R Habiby","year":"1995","unstructured":"Habiby, R., Silverman, B., Listernick, R. & Charrow, J. Precocious puberty in children with neurofibromatosis type 1. J. Pediatr. 126, 364 (1995).","journal-title":"J. Pediatr."},{"key":"2098_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0887-8994(00)00123-5","volume":"22","author":"R Vassilopoulou-Sellin","year":"2000","unstructured":"Vassilopoulou-Sellin, R., Klein, M. J. & Slopis, J. K. Growth hormone deficiency in children with neurofibromatosis type 1 without suprasellar lesions. Pediatr. Neurol. 22, 355\u2013358 (2000).","journal-title":"Pediatr. Neurol."},{"key":"2098_CR8","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s004310000531","volume":"159","author":"J Grill","year":"2000","unstructured":"Grill, J. et al. When do children with optic pathway tumors need treatment? An oncological perspective in 106 patients treated in a single center. Eur. J. Pediatr. 159, 692\u2013696 (2000).","journal-title":"Eur. J. Pediatr."},{"key":"2098_CR9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00066-003-9104-9","volume":"179","author":"RD Kortmann","year":"2003","unstructured":"Kortmann, R. D. et al. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part I: treatment modalities of radiation therapy. Strahlenther. Onko. 179, 509\u2013520 (2003).","journal-title":"Strahlenther. Onko."},{"key":"2098_CR10","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.ophtha.2003.06.008","volume":"111","author":"S Thiagalingam","year":"2004","unstructured":"Thiagalingam, S., Flaherty, M., Billson, F. & North, K. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients. Ophthalmology 111, 568\u2013577 (2004).","journal-title":"Ophthalmology"},{"key":"2098_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/ana.410410204","volume":"41","author":"R Listernick","year":"1997","unstructured":"Listernick, R., Louis, D. N., Packer, R. J. & Gutmann, D. H. Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann. Neurol. 41, 143\u2013149 (1997).","journal-title":"Ann. Neurol."},{"key":"2098_CR12","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/ICU.0000000000000587","volume":"30","author":"MK Farazdaghia","year":"2019","unstructured":"Farazdaghia, M. K., Katowitza, W. R. & Averya, R. A. Current treatment of optic nerve gliomas. Curr. Opin. Ophthalmol. 30, 356\u2013363 (2019).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"2098_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000121239","volume":"27","author":"MD Medlock","year":"1997","unstructured":"Medlock, M. D. et al. Optic chiasm astrocytoma\u2019s of childhood 1. Long-term follow-up. Pediatr. Neurosurg. 27, 121\u2013128 (1997).","journal-title":"Pediatr. Neurosurg."},{"key":"2098_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/FOC-07\/11\/E2","volume":"23","author":"MJ Binning","year":"2007","unstructured":"Binning, M. J., Liu, J. K., Kestle, J. R., Brockmeyer, D. L. & Walker, M. L. Optic pathway gliomas: a review. Neurosurg. Focus 23, 1\u20138 (2007).","journal-title":"Neurosurg. Focus"},{"key":"2098_CR15","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1200\/JCO.2002.08.087","volume":"20","author":"M Massimino","year":"2002","unstructured":"Massimino, M. et al. High response rate to cisplatin\/etoposide regimen in childhood low-grade glioma. J. Clin. Oncol. 20, 4209\u20134216 (2002).","journal-title":"J. Clin. Oncol."},{"key":"2098_CR16","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1080\/02688690310001601216","volume":"17","author":"J Astrup","year":"2003","unstructured":"Astrup, J. Natural history and clinical management of optic pathway glioma. Br. J. Neurosurg. 17, 327\u2013335 (2003).","journal-title":"Br. J. Neurosurg."},{"key":"2098_CR17","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S0887-8994(02)00628-8","volume":"28","author":"SL Tow","year":"2003","unstructured":"Tow, S. L., Chandela, S., Miller, N. R. & Avellino, A. M. Long-term outcome in children with gliomas of the anterior visual pathway. Pediatr. Neurol. 28, 262\u2013270 (2003).","journal-title":"Pediatr. Neurol."},{"key":"2098_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1227\/00006123-199002000-00010","volume":"26","author":"LA Rodriguez","year":"1990","unstructured":"Rodriguez, L. A., Edwards, M. S. & Levin, V. A. Management of hypothalamic gliomas in children. An analysis of 33 cases. Neurosurgery 26, 242\u2013247 (1990).","journal-title":"Neurosurgery"},{"key":"2098_CR19","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.13005\/bpj\/2035","volume":"13","author":"G Attina","year":"2020","unstructured":"Attina, G. et al. Management of children with optic gliomas and neurofibromatosis type 1. Biomed. Pharmacol. J. 13, 1601\u20131606 (2020).","journal-title":"Biomed. Pharmacol. J."},{"key":"2098_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3171\/2016.9.PEDS16328","volume":"19","author":"C Miller","year":"2017","unstructured":"Miller, C., Guillaume, D., Dusenbery, K., Clark, H. B. & Moertel, C. Report of effective trametinib therapy in 2 children with progressive hypothalamic optic pathway pilocytic astrocytoma: documentation of volumetric response. J. Neurosurg. Pediatr. 19, 319\u2013324 (2017).","journal-title":"J. Neurosurg. Pediatr."},{"key":"2098_CR21","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00381-018-3739-4","volume":"34","author":"SA Upadhyaya","year":"2018","unstructured":"Upadhyaya, S. A. et al. Marked functional recovery and imaging response of refractory optic pathway glioma to BRAFV600E inhibitor therapy: a report of two cases. Childs Nerv. Syst. 34, 605\u2013610 (2018).","journal-title":"Childs Nerv. Syst."},{"key":"2098_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000458525","volume":"87","author":"I Sani","year":"2017","unstructured":"Sani, I. & Albanese, A. Endocrine long-term follow-up of children with neurofibromatosis type 1 and optic pathway glioma. Horm. Res. Paediatr. 87, 179\u2013188 (2017).","journal-title":"Horm. Res. Paediatr."},{"key":"2098_CR23","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1002\/ajmg.a.38308","volume":"173","author":"P Cambiaso","year":"2017","unstructured":"Cambiaso, P. et al. Growth hormone excess in children with neurofibromatosis type-1 and optic glioma. Am. J. Med. Genet. A 173, 2353\u20132358 (2017).","journal-title":"Am. J. Med. Genet. A"},{"key":"2098_CR24","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1210\/clinem\/dgaa138","volume":"105","author":"C Santoro","year":"2020","unstructured":"Santoro, C. et al. Pretreatment endocrine disorders due to optic pathway gliomas in pediatric neurofibromatosis type 1: multicenter study. J. Clin. Endocrinol. Metab. 105, 2214\u20132221 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2098_CR25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1055\/s-2003-39788","volume":"111","author":"R Mart\u00ednez","year":"2003","unstructured":"Mart\u00ednez, R., Honegger, J., Fahlbusch, R. & Buchfelder, M. Endocrine findings in patients with optico-hypothalamic gliomas. Exp. Clin. Endocrinol. Diabetes 111, 162\u2013167 (2003).","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"2098_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/adc.45.239.13","volume":"45","author":"WA Marshall","year":"1970","unstructured":"Marshall, W. A. & Tanner, J. M. Variations in the pattern of pubertal changes in boys. Arch. Dis. Child. 45, 12\u201323 (1970).","journal-title":"Arch. Dis. Child."},{"key":"2098_CR27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/adc.44.235.291","volume":"44","author":"WA Marshall","year":"1969","unstructured":"Marshall, W. A. & Tanner, J. M. Variations in the pattern of pubertal changes in girls. Arch. Dis. Child. 44, 291\u2013303 (1969).","journal-title":"Arch. Dis. Child."},{"key":"2098_CR28","first-page":"1","volume":"8","author":"RJ Kuczmarski","year":"2000","unstructured":"Kuczmarski, R. J., Ogden, C. L. & Grummer-Strawn, L. M. CDC growth charts: United States. Adv. Data 8, 1\u201327 (2000).","journal-title":"Adv. Data"},{"key":"2098_CR29","unstructured":"Styne, D. M. in Pediatric Endocrinology 2nd edn (ed. Sperling, M. A.) 599 (Elsevier Science, 2002)."},{"key":"2098_CR30","unstructured":"Rosenfield, R. in Pediatric Endocrinology 2nd edn (ed. Sperling, M. A.) 494 (Elsevier Science, 2002)."},{"key":"2098_CR31","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1542\/peds.2008-1349","volume":"122","author":"SR Daniels","year":"2008","unstructured":"Daniels, S. R. & Greer, F. R. Committee on Nutrition: lipid screening and cardiovascular health in childhood. Pediatrics 122, 198\u2013208 (2008).","journal-title":"Pediatrics"},{"key":"2098_CR32","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III","year":"2002","unstructured":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106, 3143\u20133421 (2002).","journal-title":"Circulation"},{"key":"2098_CR33","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3928\/01913913-20160810-03","volume":"53","author":"E Parkhurst","year":"2016","unstructured":"Parkhurst, E. & Abboy, S. Optic glioma in neurofibromatosis type 1. J. Pediatr. Ophthalmol. Strabismus 53, 334\u2013338 (2016).","journal-title":"J. Pediatr. Ophthalmol. Strabismus"},{"key":"2098_CR34","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/path.2780","volume":"222","author":"JW Jeuken","year":"2010","unstructured":"Jeuken, J. W. & Wesseling, P. MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas; a novel oncogenic fusion gene with diagnostic, prognostic, and therapeutic potential. J. Pathol. 222, 324\u2013328 (2010).","journal-title":"J. Pathol."},{"key":"2098_CR35","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/cncr.11119","volume":"97","author":"M Fouladi","year":"2003","unstructured":"Fouladi, M. et al. Survival and functional outcome of children with hypothalamic\/chiasmatic tumors. Cancer 97, 1084\u20131092 (2003).","journal-title":"Cancer"},{"key":"2098_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1046\/j.1365-2265.1997.2211032.x","volume":"47","author":"PF Collet-Solberg","year":"1997","unstructured":"Collet-Solberg, P. F. et al. Endocrine outcome in long-term survivors of low-grade hypothalamic\/chiasmatic glioma. Clin. Endocrinol. 47, 79\u201385 (1997).","journal-title":"Clin. Endocrinol."},{"key":"2098_CR37","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1200\/JCO.2008.21.2738","volume":"27","author":"TE Merchant","year":"2009","unstructured":"Merchant, T. E., Conklin, H. M., Wu, S., Lustig, R. H. & Xiong, X. Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits. J. Clin. Oncol. 27, 3691\u20133697 (2009).","journal-title":"J. Clin. Oncol."},{"key":"2098_CR38","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1210\/jc.2015-2028","volume":"100","author":"HW Gan","year":"2015","unstructured":"Gan, H. W. et al. Neuroendocrine morbidity after pediatric optic gliomas: A longitudinal analysis of 166 children over 30 years. J. Clin. Endocrinol. Metab. 100, 3787\u20133799 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2098_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers14030747","volume":"14","author":"S Picariello","year":"2022","unstructured":"Picariello, S. et al. A 40-year cohort study of evolving hypothalamic dysfunction in infants and young children (<3 years) with optic pathway gliomas. Cancers 14, 1\u201316 (2022).","journal-title":"Cancers"},{"key":"2098_CR40","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1002\/cncr.28110","volume":"119","author":"K Terashima","year":"2013","unstructured":"Terashima, K. et al. Long term outcomes of centrally located low grade glioma in children. Cancer 119, 2630\u20132638 (2013).","journal-title":"Cancer"},{"key":"2098_CR41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000327584","volume":"76","author":"S Shalitin","year":"2011","unstructured":"Shalitin, S. et al. Endocrine outcome in long term survivors of childhood brain tumors. Horm. Res. Pediatr. 76, 113\u2013122 (2011).","journal-title":"Horm. Res. Pediatr."},{"key":"2098_CR42","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/S0022-3476(95)70159-1","volume":"127","author":"R Listernick","year":"1995","unstructured":"Listernick, R., Darling, C., Greenwald, M., Strauss, L. & Charrow, J. Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history. J. Pediatr. 127, 718 (1995).","journal-title":"J. Pediatr."},{"key":"2098_CR43","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1210\/jc.2002-021180","volume":"88","author":"RH Lustig","year":"2003","unstructured":"Lustig, R. H. et al. Risk factors for the development of obesity in children surviving brain tumors. J. Clin. Endocrinol. Metab. 88, 611\u2013616 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2098_CR44","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000447326","volume":"86","author":"RL Josefson","year":"2016","unstructured":"Josefson, R. L., Listernick, B., Charrow, J. & Habiby, R. L. Growth hormone excess in children with optic pathway tumors is a transient phenomenon. Horm. Res. Pediatr. 86, 35\u201338 (2016).","journal-title":"Horm. Res. Pediatr."},{"key":"2098_CR45","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jpeds.2010.09.013","volume":"158","author":"J Josefson","year":"2011","unstructured":"Josefson, J., Listernick, R., Fangusaro, J. R., Charrow, J. & Habiby, R. Growth hormone excess in children with neurofibromatosis type 1-associated and sporadic optic pathway tumors. J. Pediatr. 158, 433\u2013436 (2011).","journal-title":"J. Pediatr."},{"key":"2098_CR46","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1002\/ajmg.a.38308","volume":"173A","author":"P Cambiaso","year":"2017","unstructured":"Cambiaso, P. et al. Growth hormone excess in children with neurofibromatosis type-1 and optic glioma. Am. J. Med. Genet. 173A, 2353\u20132358 (2017).","journal-title":"Am. J. Med. Genet."},{"key":"2098_CR47","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3171\/jns.1994.81.4.0595","volume":"81","author":"TJ Manski","year":"1994","unstructured":"Manski, T. J., Haworth, C. S., Duval-Arnould, B. J. & Rushing, E. J. Optic pathway glioma infiltrating into somatostatinergic pathways in a young boy with gigantism. Case report. J. Neurosurg. 81, 595\u2013600 (1994).","journal-title":"J. Neurosurg."},{"key":"2098_CR48","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S0022-3476(89)80137-4","volume":"114","author":"R Listernick","year":"1989","unstructured":"Listernick, R., Charrow, J., Greenwald, M. J. & Esterly, N. B. Optic gliomas in children with neurofibromatosis type 1. J. Pediatr. 114, 788\u2013792 (1989).","journal-title":"J. Pediatr."},{"key":"2098_CR49","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/00000441-199201000-00010","volume":"303","author":"DT Stein","year":"1992","unstructured":"Stein, D. T. Southwestern Internal Medicine Conference. New developments in the diagnosis and treatment of sexual precocity. Am. J. Med. Sci. 303, 53\u201371 (1992).","journal-title":"Am. J. Med. Sci."},{"key":"2098_CR50","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/(SICI)1096-8628(19991203)87:4<317::AID-AJMG7>3.0.CO;2-X","volume":"87","author":"M Clementi","year":"1999","unstructured":"Clementi, M. et al. Neurofibromatosis type 1 growth charts. Am. J. Med. Genet. 87, 317\u2013323 (1999).","journal-title":"Am. J. Med. Genet."},{"key":"2098_CR51","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1136\/jmg.37.12.933","volume":"37","author":"J Szudek","year":"2000","unstructured":"Szudek, J., Birch, P. & Friedman, J. M. Growth in North American white children with neurofibromatosis 1 (NF1). J. Med. Genet. 37, 933\u2013938 (2000).","journal-title":"J. Med. Genet."},{"key":"2098_CR52","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1200\/JCO.1997.15.8.2792","volume":"15","author":"A Gajjar","year":"1997","unstructured":"Gajjar, A. et al. Low-grade astrocytoma: a decade of experience at St. Jude Children\u2019s Research Hospital. J. Clin. Oncol. 15, 2792\u20132799 (1997).","journal-title":"J. Clin. Oncol."},{"key":"2098_CR53","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/pbc.21563","volume":"51","author":"PG Fisher","year":"2008","unstructured":"Fisher, P. G. et al. Outcome analysis of childhood low-grade astrocytomas. Pediatr. Blood Cancer 51, 245\u2013250 (2008).","journal-title":"Pediatr. Blood Cancer"},{"key":"2098_CR54","first-page":"1257","volume":"12","author":"T Stokland","year":"2010","unstructured":"Stokland, T. et al. A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702). Neuro. Oncol. 12, 1257\u20131268 (2010).","journal-title":"Neuro. Oncol."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02098-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02098-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02098-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T18:06:27Z","timestamp":1674669987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02098-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,10]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["2098"],"URL":"https:\/\/doi.org\/10.1038\/s41390-022-02098-5","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,10]]},"assertion":[{"value":"6 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the local Institutional Review Board. Patient consent was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}